tiprankstipranks
Trending News
More News >

ImmuPharma Announces Change in Major Shareholder Holdings

Story Highlights
ImmuPharma Announces Change in Major Shareholder Holdings

Confident Investing Starts Here:

ImmuPharma ( (GB:IMM) ) just unveiled an update.

ImmuPharma has announced a change in its major holdings, with Lanstead Capital Investors LP reducing its stake from 16.13% to 12.99% of voting rights. This adjustment in holdings may influence the company’s shareholder dynamics and could have implications for its strategic decisions and market perception.

More about ImmuPharma

ImmuPharma is a pharmaceutical company that focuses on the development and commercialization of innovative drugs. The company operates in the biotech industry, primarily targeting unmet medical needs through its proprietary drug development programs.

Average Trading Volume: 3,152,205

Technical Sentiment Signal: Hold

Current Market Cap: £13.27M

Find detailed analytics on IMM stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App